Higher prenatal fluoride exposure may influence fetal kidney development through epigenetic changes in the placenta, potentially affecting long-term health. This #ASNCJASN study highlights the need for further research and careful risk–benefit assessment. https://twp.ai/9OVjvB

Early, honest conversations about values and goals in dialysis patients help ensure end‑of‑life care aligns with what matters most, reducing unnecessary suffering and enabling a more peaceful, patient-centered death, according to #ASNCJASN. https://twp.ai/9OVjRC

The June issue of Kidney News is now online! Topics this month include: ⦁ NephroEconomics 2026: Costs and Innovation ⦁ Guiding Obstetric Teams in Pregnancy Associated AKI and more! Explore the issue: https://twp.ai/9OXJCz #ASNKidneyNews Kenar Jhaveri, MD#ASNKidneyNews

SMRT assay detects almost all VNTR-associated frameshift mutations, outperforming the CLIA-approved probe-extension test, according to study in #ASNJASN. Additionally, MUC1fs immunohistochemistry improves diagnostic capabilities in patients with uncertain genetics. https://twp.ai/9PcGR4

Learn when to select sodium zirconium cyclosilicate (SZC) vs patiromer (PAT) to treat hyperkalemia in patients with cardio‑kidney disease from this #perspective in #ASNCJASN. https://twp.ai/9OXOcA

Neonatal AKI affects nearly 30% of ICU infants and raises mortality fivefold. New miniaturized CKRT platforms like CARPEDIEM and HF20 are transforming care, finally giving infants <5 kg safe, precise dialysis options. Read more in #ASNKidneyNews: https://twp.ai/9OW0ZA#ASNKidneyNews:

The ASN journals, #ASNCJASN, #ASNJASN, and #ASNKidney360, recognize and honor the outstanding work of junior colleagues in their early stages of nephrology careers by awarding Trainee of the Year awards. Learn more about the opportunity here: https://twp.ai/9OVwBi

New research in #ASNJASN shows that, for many women with ADPKD, pregnancy does not accelerate kidney disease progression, helping reduce uncertainty, improve counseling, and support informed family planning decisions. https://twp.ai/9OW2h6

"For individuals living with CKD or kidney failure, kidney transplantation offers a second chance at life. For many transplant recipients, the emotional weight of the second chance can be just as profound as the physical recovery..." Read the full article in #ASNKidneyNews: https://twp.ai/9OW1aP#ASNKidneyNews:

Gadolinium-based contrast agent (GBCA) risk can lead to missed diagnoses or preventable harm. Clear evidence and transparent communication are essential to ensure patients with kidney disease get the right imaging at the right time with the lowest possible risk. #ASNCJASN https://twp.ai/9OVjQ8

New study in #ASNJASN published simultaneously with #ERA26 compared efficacy & safety of steady concentration PD using Carry Life UF system in home setting. Treatment resulted in increased UF volume, sodium removal, & glucose UF efficiency compared to 2.5% dextrose control https://twp.ai/9OWCWa

The selective cytopheretic device (SCD) is an extracorporeal cartridge designed to modulate activated neutrophils and monocytes. Early studies suggest a role in inflammation-mediated AKI. Read more in #ASNKidneyNews: https://twp.ai/9OW1aD#ASNKidneyNews:

Do loop diuretics raise atrial fibrillation (AF) risk in CKD? In 4,607 adults with CKD, baseline loop diuretic use was linked to a 41% higher risk of AF hospitalization. Risk was consistent across sex & CKD stage, stronger with heart failure. #ASNKidney360 https://twp.ai/9OWd7u

New Podcast: In this podcast, authors discuss their new paper in #ASNKidney360: Kidney Function Decline in Sickle Cell Disease: Associations with Renin-Angiotensin System Inhibitors" Tune in here: https://twp.ai/9OWCMp

The Kidney Innovation Accelerator (KidneyX) has launched its next prize competition to EMPOWER living kidney donation. Read all about the new prize In #ASNKidneyNews: https://twp.ai/9OW1a1#ASNKidneyNews:

Could a modifiable treatment choice at dialysis initiation (HDF vs. HD) significantly improve survival, reduce cardiovascular deaths, and influence clinical practice at scale in a population with high mortality and limited treatment options? Find out in #ASNCJASN. kidney.pub/CJASN1063

#ASNJASN study demonstrates that a noninvasive blood test (dd-cfDNA), when combined with clinical data, can meaningfully improve how clinicians detect and manage kidney transplant rejection, while reducing unnecessary biopsies and uncertainty. kidney.pub/JASN1116

The June issue of JASN is now available online! Topics covered this month include: - Effect of Purinergic P2X1 Receptors on Renal Vascular Resistance - Genetics and Steroid Responsiveness in IgA Nephropathy - and more Check out the issue here: kidney.pub/JASN-0626 #ASNJASN Cover by Huang et al.

Why does your IgA nephropathy care depend on who you see? In a Manitoba study published in #ASNKidney360, doctors drove 31% of variability in biopsy timing and 7% in steroid use. kidney.pub/KID1232 Bryce Barr

Hemoadsorption is showing up more often in hematology emergencies. For nephrologists, device specificity matters: filters ≠ cartridges. Understanding what each removes—and what it might unintentionally remove—is key. Read more in #ASNKidneyNews: kidney.pub/KN1805-12#ASNKidneyNews:

Pediatric nephrology collection highlights recent pediatric kidney research and reviews covering topics such as AKI, vasculitis prognosis, infant hypertension, transplantation, palliative care, cancer-related ESKD risk, and treatments for nephrotic syndrome. kidney.pub/PedsNeph

Large retrospective cohort study in #ASNCJASN shows that high-volume hemodiafiltration (HV-HDF) may help patients stay healthier, out of the hospital, and reduce healthcare costs. kidney.pub/CJASN0955

#Perspective highlights how the Cardiovascular Kidney Metabolic Health (CKMH) Framework presents cardiovascular, kidney, and metabolic disease as an interconnected, patient‑centered condition, stressing that effective care depends on a coordinated approach. kidney.pub/KID1237#Perspective

A small phase 2 trial suggests rilparencel may slow CKD progression in diabetes by ~78%. Early but promising step toward regenerative kidney treatments; phase 3 underway. kidney.pub/CJASN0969

The ASN journals, #ASNCJASN, #ASNJASN, and #ASNKidney360, recognize and honor the outstanding work of junior colleagues in their early stages of nephrology careers by awarding Trainee of the Year awards. Learn more about the opportunity here: kidney.pub/traineeprize

Extracorporeal blood purification represents a promising adjunct to standard critical care nephrology and may help interrupt key pathobiological pathways in septic shock. Read up on the latest research and guidance in #ASNKidneyNews: kidney.pub/KN1805-11

According to a #review in #ASNJASN, pilot trials are the gatekeepers that determine whether a full-scale Randomized Clinical Trial (RCT) would work successfully in complex CKD and dialysis populations. kidney.pub/JASN1146

How did early permanent vascular access use change among patients initiating hemodialysis, and what do the trends in central venous catheter use, AVF/AVG placement rates, and declining hazard ratios suggest about adherence to recommendations? Find out from #ASNCJASN. kidney.pub/CJASN1076

Researchers demonstrate that sex and disease status impact the kinetics and mechanism of niche filling in the kidney according to #basicresearch in #ASNKidney360. kidney.pub/KID1217

The May issue of Kidney360 is now available online! Topics covered this month include: - A behavioral nudge to discuss CKM - Advances in mouse models of CKD to reduce fibrosis - and more Check out the issue here: kidney.pub/K360-0526 #ASNKidney360 Cover by Qiu et al.

Extracorporeal blood purification is moving beyond passive filtration. The future, as outlined here, combines smart sorbent materials, embedded biosensors, and AI-driven control to turn dialysis into a dynamic, adaptive system. Read more in #ASNKidneyNews: kidney.pub/KN1805-10 @wisit661.bsky.social#ASNKidneyNews:

Maternal ketosis, especially from ketogenic diets, may impair fetal kidney development in ways that persist into adulthood. As keto diets become more common, understanding these risks is crucial for clinicians, public health, and anyone who may become pregnant. #ASNJASN kidney.pub/JASN1126

Read the ASN Publications collection of articles highlights rapidly evolving research and treatment for kidney-heart disorders, including cardiovascular-kidney-metabolic syndrome. kidney.pub/kidneyheart

In this month's Creative Cortex in #ASNKidneyNews, a work titled "Watch Your GFR". Learn more: kidney.pub/KN1805-17#ASNKidneyNews,

In a 24‑week study of 101 adults with CKD and excess weight, semaglutide 2.4 mg/week led to about 10% weight loss. Importantly, these body‑composition changes didn’t distort kidney function estimates (creatinine‑ or cystatin‑based eGFR, or measured GFR). #ASNCJASN kidney.pub/CJASN1051

#ASNKidney360 study validates a next-generation sequencing assay, designed to predict early acute rejection in kidney transplant recipients by evaluating a 29-gene transcriptomic profile. kidney.pub/KID1208 Roslyn B Mannon

Authors of an article in #ASNJASN report that as home hemodialysis use grows, realizing its full benefits will require reducing infection rates, since infection remains a leading cause of death and limits how long patients can stay on home therapy. kidney.pub/JASN1140 Eric Weinhandl

#CaseReport in #ASNKidney360 shows that when minimal change disease (MCD) is refractory, relapsing, or atypical, clinicians should maintain a high index of suspicion for occult malignancy, including Hodgkin’s lymphoma. kidney.pub/KID1225 Kenar Jhaveri, MD

This month, #ASNKidneyNews has a special section on Critical Care in Nephrology. Check out articles curated to cover the field's latest: kidney.pub/KN1805-09#ASNKidneyNews

Management of kidney transplantation should focus on controlling rejection and preventing new antibodies. Learn why in this #ASNJASN study. kidney.pub/JASN1125

Can timing of reductions in kidney function help predict outcomes in heart failure? Read an article about the recent findings in #ASNKidneyNews: kidney.pub/KN1805-19#ASNKidneyNews:

The complement factor B inhibitor iptacopan effectively slows decline in kidney function in patients with immunoglobulin A nephropathy (IgAN), according to final results of a randomized trial in The New England Journal of Medicine. Read a recap in #ASNKidneyNews: kidney.pub/KN1805-20#ASNKidneyNews:

New in #ASNKidneyNews: "AI in Nephrology Hands-On Primer: Practical Applications and Clinical Integration." Read what experts in the field have to say after taking part in an innovative workshop: kidney.pub/KN1805-08 @wisit661.bsky.social#ASNKidneyNews:

The ASN journals, #ASNCJASN, #ASNJASN, and #ASNKidney360, recognize and honor the outstanding work of junior colleagues in their early stages of nephrology careers by awarding Trainee of the Year awards. Learn more about the opportunity here: kidney.pub/traineeprize

What is the timing of vascular access creation in comparison to hemodialysis initiation in older European people with ESKD? Read this #ASNKidney360 study to find out. kidney.pub/KID1180

New Podcast: Dr. Yu summarizes the main findings from his study on the "Relationship between total kidney volume and estimated glomerular filtration rate in autosomal dominant polycystic kidney disease" on behalf of his colleagues. #ASNCJASN Tune in: kidney.pub/CPOD0992 Alan Yu

🎉 ASN Kidney News welcomes Sam Kant as the next Editor-in-Chief, effective January 1, 2027. He’s a Consultant Nephrologist and Transplant Physician at @svuh and @ucddublin, serving as Deputy Editor since 2023 and an editorial board member since 2019. Explore Kidney News: www.kidneynews.org/

#ASNJASN remembers Dr. Murray Sheldon, a pioneering surgeon and steadfast advocate for patient‑centered innovation who reshaped medical device development and kidney care, leaving a legacy of safer, accessible, and more innovative therapies. kidney.pub/JASN1135 Glenda Roberts

Equity in transplantation isn’t only about the match run. Referral patterns, evaluation barriers, committee decisions, geography, and administrative burden all shape who reaches the waitlist. Read the full Fellows First article equity in kidney allocation in #ASNKidneyNews: kidney.pub/KN1805-07#ASNKidneyNews:

Current observational studies cannot determine causal effects because they analyze achieved sodium correction rather than predefined treatment strategies, creating time‑varying confounding, selection bias, and limited clinical relevance, according to an #ASNJASN #perspective. kidney.pub/JASN1134